PT-141 Research Documentation

Research-use-only scope: This page documents the BioPep USA PT-141 catalog item and its available COA. It does not provide preparation, dosing, injection, human-use, animal-use, therapeutic, diagnostic, cosmetic, or clinical guidance.

PT-141 is the name used on the BioPep USA product page and lot record. Published sources may also use the name Bremelanotide.

Product and naming details

BioPep USA product: PT-141
Name also found in published sources: Bremelanotide
Current size: 10mg
Current quantity options: Single Vial and Pack of 10

Available PT-141 certificate of analysis

The COA library contains one matching 10mg record:

Lot: BU-2061592-P
Reported purity: 99.25%
Analysis date: May 3, 2026
Document: Open the PT-141 COA PDF

Matching the product to the record

Use the product name, 10mg size, and lot number together. A published source using the name Bremelanotide can help with terminology, but it does not replace the lot-specific COA. The PT-141 research notes list the source references separately from the commercial record.

What the COA establishes

The COA reports information for the identified lot, including the stated purity result and analysis date. It does not provide use instructions or establish a medical, therapeutic, diagnostic, cosmetic, human-use, or animal-use purpose.

Browse all records in the BioPep USA COA library, or contact support with a lot-specific question.

Last reviewed: July 20, 2026.